ENTITY

Mallinckrodt Plc (MNK US)

24
Analysis
Health Care • United States
Mallinckrodt PLC develops, manufactures and markets specialty pharmaceutical products and diagnostic imaging agents. The Company specializes in the manufacturing of pain management medications. Mallinckrodt offers its products to major wholesalers and retail drug store chains around the world.
more
bearish•Mallinckrodt Plc
•08 Aug 2026 05:29

Primer: Mallinckrodt Plc (MNK US) - Aug 2026

Mallinckrodt has recently emerged from its second Chapter 11 bankruptcy, significantly reducing its debt load but also resulting in the...

Share
bullish•S&P 500 INDEX
•08 Aug 2018 04:51

S&P 500: Outlook Constructive but Concerns Remain

As the S&P 500 nears the 2,873 January high - a critical hurdle - short-term Sector leadership changes give us reason for pause. While we...

Logo
478 Views
Share
•09 Feb 2017 09:14

Trump Health Effect: What Is Next for the Consumer Health Industry Under Trump's Leadership?

While the US consumer health industry will remain a strong centre for investment, development and technology innovation in 2017 and is expected to...

•29 Nov 2016 13:10

Actionable Ideas in the Biotechnology and Pharmaceutical Sectors (Incl. Insider Buying): November 28

Ziopharm Oncology Inc (ZIOP US) announced impressive survival data for its immune-boosting therapy AD-RTS-hIL-12 + veledimex in recurrent pediatric...

•12 Nov 2016 07:59

Just In: Trump's Preliminary Plan to Repeal the Affordable Care Act

Among one of his first initiatives, U.S. President-elect Trump posted a preliminary plan to repeal the Affordable Care Act (ACA) on his transition...

x